BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25606577)

  • 1. Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue.
    Bauman TM; Vezina CM; Huang W; Marker PC; Peterson RE; Ricke WA
    Am J Clin Exp Urol; 2014; 2(4):313-22. PubMed ID: 25606577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression.
    Bauman TM; Vezina CM; Ricke EA; Halberg RB; Huang W; Peterson RE; Ricke WA
    Hum Pathol; 2016 May; 51():124-33. PubMed ID: 27067790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
    Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
    Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential impact of paired patient-derived BPH and normal adjacent stromal cells on benign prostatic epithelial cell growth in 3D culture.
    Chen W; Pascal LE; Wang K; Dhir R; Sims AM; Campbell R; Gasper G; DeFranco DB; Yoshimura N; Wang Z
    Prostate; 2020 Oct; 80(14):1177-1187. PubMed ID: 32659026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic versus proliferative activities in human benign prostatic hyperplasia.
    Kyprianou N; Tu H; Jacobs SC
    Hum Pathol; 1996 Jul; 27(7):668-75. PubMed ID: 8698310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.
    Li F; Pascal LE; Stolz DB; Wang K; Zhou Y; Chen W; Xu Y; Chen Y; Dhir R; Parwani AV; Nelson JB; DeFranco DB; Yoshimura N; Balasubramani GK; Gingrich JR; Maranchie JK; Jacobs BL; Davies BJ; Hrebinko RL; Bigley JD; McBride D; Guo P; He D; Wang Z
    Prostate; 2019 Aug; 79(11):1226-1237. PubMed ID: 31212363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia.
    O'Malley KJ; Eisermann K; Pascal LE; Parwani AV; Majima T; Graham L; Hrebinko K; Acquafondata M; Stewart NA; Nelson JB; Yoshimura N; Wang Z
    Prostate; 2014 Jun; 74(8):892-900. PubMed ID: 24711254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-Specific Deletion of Cdh1 Induces Murine Prostatic Inflammation and Bladder Overactivity.
    Pascal LE; Mizoguchi S; Chen W; Rigatti LH; Igarashi T; Dhir R; Tyagi P; Wu Z; Yang Z; de Groat WC; DeFranco DB; Yoshimura N; Wang Z
    Endocrinology; 2021 Jan; 162(1):. PubMed ID: 33211830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
    Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
    Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia.
    Nassis L; Frauman AG; Ohishi M; Zhuo J; Casley DJ; Johnston CI; Fabiani ME
    J Pathol; 2001 Dec; 195(5):571-9. PubMed ID: 11745693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia.
    Choi J; Shendrik I; Peacocke M; Peehl D; Buttyan R; Ikeguchi EF; Katz AE; Benson MC
    Urology; 2000 Jul; 56(1):160-6. PubMed ID: 10869659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.
    Barclay WW; Woodruff RD; Hall MC; Cramer SD
    Endocrinology; 2005 Jan; 146(1):13-8. PubMed ID: 15471963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
    Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
    Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.
    Inamura S; Ito H; Shinagawa T; Tsutsumiuchi M; Taga M; Kobayashi M; Yokoyama O
    Prostate; 2018 Jul; 78(10):743-752. PubMed ID: 29608020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin Mediates Prostate Stromal Cell Proliferation, Smooth Muscle Contraction, and Mitochondrial Function in Benign Prostate Hyperplasia.
    Wang X; Guo L; Liu G; Liu T
    Diabetes Metab Syndr Obes; 2023; 16():3261-3273. PubMed ID: 37876983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer.
    Habermann H; Ray V; Habermann W; Prins GS
    J Urol; 2001 Dec; 166(6):2267-72. PubMed ID: 11696749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis.
    Luo J; Dunn T; Ewing C; Sauvageot J; Chen Y; Trent J; Isaacs W
    Prostate; 2002 May; 51(3):189-200. PubMed ID: 11967953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
    Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
    J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.